Crescendo Bioscience
Nable more effective management of autoimmune and inflammatory diseases by providing quantitative, objective molecular tests and disease information services to rheumatologists and patients. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
CAD368m (Public information from Feb 2014)
San Francisco California (HQ)
Authorizing premium user...